Start
Completion

Comparing Ketamine and Propofol Anesthesia for Electroconvulsive Therapy

CompletedRegisteredCTG

Randomised, quadruple-blind, parallel Phase IV study (n=27) comparing ketamine (0.75 mg/kg IV) versus propofol (1 mg/kg IV) as anaesthetic agents for ECT in treatment-resistant major depressive disorder.

Details

This parallel-group randomised trial tests whether ketamine as the anaesthetic for ECT improves depressive symptoms compared with propofol in patients with treatment-resistant depression.

Patients receive anaesthesia with ketamine 0.75 mg/kg IV or propofol 1 mg/kg IV, both with remifentanil 1 mcg/kg; efficacy assessed by MADRS and clinical measures.

Planned interim safety analyses were described after 20 and 40 patients; an independent safety committee reviews adverse events and may adjust dosing or discontinue the trial.

Topics:Treatment-Resistant Depression (TRD)

Registry

Registry linkNCT01935115